FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean
Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America
Mark Crowther, MD, MSc, FRCPC and Marco Donadini, MD
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.